H. Mabuchi

发表

Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention　- From the CREDO-Kyoto Registry Cohort-3.

Takeshi Kimura, T. Morimoto, H. Shiomi, 2020, Circulation journal : official journal of the Japanese Circulation Society.

Serum lipoprotein lipase mass: clinical significance of its measurement.

H. Mabuchi, J. Kobayashi, A. Nohara, 2007, Clinica chimica acta; international journal of clinical chemistry.

Novel mutations of cholesteryl ester transfer protein (CETP) gene in Japanese hyperalphalipoproteinemic subjects.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2012, Clinica chimica acta; international journal of clinical chemistry.

Effects of NK-104, a new hydroxymethylglutaryl-coenzyme reductase inhibitor, on low-density lipoprotein cholesterol in heterozygous familial hypercholesterolemia. Hokuriku NK-104 Study Group.

H. Mabuchi, J. Koizumi, K. Kajinami, 2000, The American journal of cardiology.

A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia.

J. Sasaki, N. Yamada, H. Mabuchi, 2002, Atherosclerosis.

Clinical Efficacy of Pitavastatin, a New 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitor, in Patients with Hyperlipidemia

J. Sasaki, N. Yamada, H. Mabuchi, 2002, Arzneimittelforschung.

Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia.

H. Mabuchi, A. Nohara, Akihiro Inazu, 2002, Atherosclerosis.

Noninvasive prediction of coronary atherosclerosis by quantification of coronary artery calcification using electron beam computed tomography: comparison with electrocardiographic and thallium exercise stress test results.

H. Mabuchi, K. Kajinami, N. Takekoshi, 1995, Journal of the American College of Cardiology.

T‐peak to T‐end interval may be a better predictor of high‐risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin i mutation than qt dispersion

K. Hayashi, H. Mabuchi, M. Yamaguchi, 2002, Clinical cardiology.

T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity.

H. Mabuchi, M. Yamaguchi, M. Shimizu, 2003, Clinical science.

Aortic Root Calcification Score as an Independent Factor for Predicting Major Adverse Cardiac Events in Familial Hypercholesterolemia

K. Hayashi, M. Yamagishi, H. Mabuchi, 2018, Journal of atherosclerosis and thrombosis.

Severity of pulmonary embolism at initial diagnosis and long-term clinical outcomes: From the COMMAND VTE Registry.

M. Toyofuku, Takeshi Kimura, Takao Kato, 2021, International journal of cardiology.

Risk factors of thrombotic recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, Journal of Thrombosis and Thrombolysis.

Periprocedural management and clinical outcomes of invasive procedures after venous thromboembolism: from the COMMAND VTE registry

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, Journal of Thrombosis and Thrombolysis.

Impact of no, distal, and proximal deep vein thrombosis on clinical outcomes in patients with acute pulmonary embolism: From the COMMAND VTE registry.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2020, Journal of cardiology.

Sex Differences in Clinical Characteristics and Outcomes of Patients With Venous Thromboembolism　- From the COMMAND VTE Registry.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2019, Circulation journal : official journal of the Japanese Circulation Society.

Thrombolysis with tissue plasminogen activator in patients with acute pulmonary embolisms in the real world: from the COMMAND VTE registry

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2019, Journal of Thrombosis and Thrombolysis.

Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2019, Thrombosis and Haemostasis.

Effect of Statins on Recurrent Venous Thromboembolism (from the COMMAND VTE Registry).

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2019, The American journal of cardiology.

Clinical Characteristics and Outcomes of Venous Thromboembolisms According to an Out-of-Hospital vs. In-Hospital Onset　- From the COMMAND VTE Registry.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2019, Circulation journal : official journal of the Japanese Circulation Society.

The association of recurrence and bleeding events with mortality after venous thromboembolism: From the COMMAND VTE Registry.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2019, International journal of cardiology.

Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2019, Thrombosis research.

Validation of simplified PESI score for identification of low-risk patients with pulmonary embolism: From the COMMAND VTE Registry

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2018, European heart journal. Acute cardiovascular care.

Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2018, Heart and Vessels.

Anticoagulation Therapy for Venous Thromboembolism in the Real World　- From the COMMAND VTE Registry.

Takeshi Kimura, T. Morimoto, H. Shiomi, 2018, Circulation journal : official journal of the Japanese Circulation Society.

Influence of baseline anemia on long-term clinical outcomes in patients with venous thromboembolism: from the COMMAND VTE registry

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2019, Journal of Thrombosis and Thrombolysis.

Influence of Baseline Platelet Count on Outcomes in Patients With Venous Thromboembolism (from the COMMAND VTE Registry).

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2018, The American journal of cardiology.

Abstract 18157: Impact of Betatrophin (ANGPTL8) R59W Mutation for Future Diabetes, and Minimal Modification of Circulating Betatrophin With Strong Statins

M. Yamagishi, H. Mabuchi, A. Nohara, 2015 .

Effects of hepatic lipase gene promoter nucleotide variations on serum HDL cholesterol concentration in the general Japanese population

H. Mabuchi, Akihiro Inazu, Yoshiko Nishimura, 2001, Journal of Human Genetics.

Metabolic adjustments in normal and diabetic pregnancy.

H. Mabuchi, M. Childs, R. Knopp, 1981, Clinical obstetrics and gynecology.

Phenotypic differences between electrocardiographic and echocardiographic determination of hypertrophic cardiomyopathy in genetically affected subjects

H. Mabuchi, M. Shimizu, H. Ino, 2005, Journal of internal medicine.

Differences in diagnostic value of four electrocardiographic voltage criteria for hypertrophic cardiomyopathy in a genotyped population.

K. Hayashi, H. Mabuchi, M. Shimizu, 2005, The American journal of cardiology.

Electrocardiographic events and cholesterol reduction with pravastatin in patients with hypercholesterolemia: the Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial.

H. Mabuchi, J. Koizumi, S. Miyamoto, 2005, International journal of cardiology.

Cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy with malignant ventricular tachyarrhythmias

J. Taki, K. Hayashi, H. Mabuchi, 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population.

H. Mabuchi, A. Nohara, Akihiro Inazu, 2002, Atherosclerosis.

ATP-binding cassette transporter G8 M429V polymorphism as a novel genetic marker of higher cholesterol absorption in hypercholesterolaemic Japanese subjects.

H. Mabuchi, J. Kobayashi, A. Nohara, 2005, Clinical science.

Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism

T. Okamura, H. Mabuchi, M. Kawashiri, 2003, Journal of Molecular Medicine.

Raloxifene promotes adipocyte differentiation of 3T3-L1 cells.

Hiroshi Sato, H. Mabuchi, J. Kobayashi, 2006, European journal of pharmacology.

Diabetes progression from "high-normal" glucose in school teachers.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2010, Internal medicine.

D-dimer levels at diagnosis and long-term clinical outcomes in venous thromboembolism: from the COMMAND VTE Registry

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2019, Journal of Thrombosis and Thrombolysis.

Iron accumulation in the liver of male patients with Wilson's disease.

H. Mabuchi, H. Miyajima, S. Kono, 2001 .

Iron accumulation in the liver of male patients with Wilson's disease

H. Mabuchi, H. Miyajima, S. Kono, 2001, American Journal of Gastroenterology.

Mutational analysis of ATP7B and genotype–phenotype correlation in Japanese with Wilson's disease

H. Mabuchi, M. Onji, M. Onji, 2000, Human mutation.

A new variant deletion of a copper-transporting P-type ATPase gene found in patients with Wilson's disease presenting with fulminant hepatic failure

H. Mabuchi, T. Okada, Y. Takeda, 2000, Journal of Gastroenterology.

Familial cholesteryl ester transfer protein deficiency is associated with triglyceride-rich low density lipoproteins containing cholesteryl esters of probable intracellular origin.

A. Tall, H. Mabuchi, Akihiro Inazu, 1991, Journal of lipid research.

Transcatheter aortic valve implantation versus conservative management for severe aortic stenosis in real clinical practice

M. Toyofuku, C. Izumi, Takeshi Kimura, 2019, PloS one.

Retinoid X receptor heterodimer variants and cardiovascular risk factors.

H. Mabuchi, J. Kobayashi, A. Nohara, 2009, Journal of atherosclerosis and thrombosis.

Strategy for treating elderly Japanese with hypercholesterolemia *

Y. Matsuzawa, T. Kita, J. Sasaki, 2004 .

Comparison of waist circumference with body mass index for predicting abdominal adipose tissue.

M. Yamagishi, K. Miura, H. Mabuchi, 2009, Diabetes research and clinical practice.

Cholesteryl ester transfer protein inhibitor (JTT-705) and the development of atherosclerosis in rabbits with severe hypercholesterolaemia.

H. Mabuchi, A. Nohara, Akihiro Inazu, 2002, Clinical science.

Effect of Bilirubin UDP Glucuronosyltransferase 1 Gene TATA Box Genotypes on Serum Bilirubin Concentrations in Chronic Liver Injuries

A. Suzuki, H. Mabuchi, H. Doyama, 2000, Hepatology.

Development of coronary heart disease in familial hypercholesterolemia.

H. Mabuchi, J. Koizumi, M. Shimizu, 1989, Circulation.

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody

M. Krempf, G. Luc, P. Hopkins, 2015, Circulation. Cardiovascular genetics.

Association between CTLA-4 +49 A/G polymorphism and type 1B diabetes in Japanese population

H. Mabuchi, J. Kobayashi, K. Yagi, 2004, Endocrine.

Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.

H. Mabuchi, X. Jiang, Akihiro Inazu, 1994, The Journal of clinical investigation.

Synthesis of novel 4,1-benzoxazepine derivatives as squalene synthase inhibitors and their inhibition of cholesterol synthesis.

H. Mabuchi, T. Nishimoto, M. Kori, 2002, Journal of medicinal chemistry.

Inhibition of Rac activation as a mechanism for negative regulation of actin cytoskeletal reorganization and cell motility by cAMP.

N. Sugimoto, H. Mabuchi, Y. Takuwa, 2005, The Biochemical journal.

Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2020, Thrombosis research.

Pseudohomozygous type II hyperlipoproteinemia

H. Mabuchi, S. Ohtaki, Keisuke Hamada, 1982, Japanese Journal of Human Genetics.

Serum lipid and lipoprotein levels in Japanese patients with familial hypercholesterolemia.

H. Mabuchi, J. Koizumi, K. Ueda, 1979, Atherosclerosis.

Images in cardiovascular medicine. Adult patient with isolated noncompaction of ventricular myocardium.

H. Ikeda, H. Mabuchi, M. Shimizu, 2005, Circulation.

Post-intervention minimal stent area as a predictor of target lesion revascularization after everolimus-eluting stent implantation for in-stent restenosis: a single-center observational study.

Takeshi Kimura, T. Morimoto, T. Takeda, 2019, Coronary artery disease.

Q-T peak dispersion in congenital long QT syndrome: possible marker of mutation of HERG.

K. Hayashi, H. Mabuchi, M. Yamaguchi, 2003, Circulation Journal.

Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis

H. Mabuchi, Akihiro Inazu, J. Koizumi, 2001, Clinical chemistry and laboratory medicine.

Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia.

H. Mabuchi, J. Koizumi, K. Ueda, 1985, Atherosclerosis.

Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients.

H. Mabuchi, J. Kobayashi, A. Nohara, 2005, Journal of atherosclerosis and thrombosis.

Marked aortic valve stenosis progression after receiving long-term aggressive cholesterol-lowering therapy using low-density lipoprotein apheresis in a patient with familial hypercholesterolemia.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2009, Circulation journal : official journal of the Japanese Circulation Society.

Relationship Between Coronary Events and Serum Cholesterol During 10 Years of Low-Dose Simvastatin Therapy

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2008 .

Cholesteryl ester transfer protein inhibitors: new strategies for raising high-density lipoprotein cholesterol

H. Mabuchi, Akihiro Inazu, 2006 .

Efficacy of colestimide coadministered with atorvastatin in japanese patients with heterozygous familial hypercholesterolemia (FH).

H. Mabuchi, J. Kobayashi, A. Nohara, 2005, Circulation journal : official journal of the Japanese Circulation Society.

Difference in the risk factors for coronary, renal and other peripheral arteriosclerosis in heterozygous familial hypercholesterolemia.

H. Mabuchi, J. Kobayashi, Akihiro Inazu, 2004, Circulation journal : official journal of the Japanese Circulation Society.

Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients.

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2003, Circulation journal : official journal of the Japanese Circulation Society.

Effect of ACE gene polymorphism on age at renal death in polycystic kidney disease in Japan.

T. Onoe, I. Miyamori, H. Mabuchi, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Type III hyperlipoproteinemia exaggerated by Sheehan's syndrome with advanced systemic atherosclerosis: a 28-year clinical course.

H. Mabuchi, J. Kobayashi, A. Nohara, 2005, Circulation journal : official journal of the Japanese Circulation Society.

Intermediate‐density Lipoprotein and Cholesterol‐rich Very Low Density Lipoprotein in Angiographically Determined Coronary Artery Disease

H. Mabuchi, J. Koizumi, K. Ueda, 1981, Circulation.

A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency.

H. Suzuki, H. Iso, T. Okamura, 1998, Preventive medicine.

Coronary angiographic characteristics in Japanese patients with heterozygous familial hypercholesterolemia.

H. Mabuchi, J. Koizumi, M. Shimizu, 1987, Atherosclerosis.

Effects of CS-514 on serum lipoprotein lipid and apolipoprotein levels in patients with familial hypercholesterolemia.

H. Mabuchi, T. Wakasugi, K. Kajinami, 1987, Metabolism: clinical and experimental.

Primary Cardiovascular Events and Serum Lipid Levels in Elderly Japanese with Hypercholesterolemia Undergoing 6‐Year Simvastatin Treatment: A Subanalysis of the Japan Lipid Intervention Trial

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2004, Journal of the American Geriatrics Society.

Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT).

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2002, Circulation journal : official journal of the Japanese Circulation Society.

Design and baseline characteristics of a cohort study in Japanese patients with hypercholesterolemia: the Japan lipid intervention trial (J-LIT)

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2000 .

Correlation between myocardial dysfunction and changes in myosin isoenzymes in diabetic rat hearts.

H. Mabuchi, M. Shimizu, H. Ino, 1996, Journal of diabetes and its complications.

Effects of metabolic control on ventricular function in type 2 diabetic patients.

H. Mabuchi, K. Ueda, T. Takegoshi, 1992, Internal medicine.

Analysis of serum lipid levels in Japanese men and women according to body mass index. Increase in risk of atherosclerosis in postmenopausal women. Research Group on Serum Lipid Survey 1990 in Japan.

Y. Matsuzawa, T. Kita, H. Mabuchi, 1999, Atherosclerosis.

Current State of and Recent Trends in Serum Lipid Levels in the General Japanese Population

H. Mabuchi, 1996 .

Removal of apolipoprotein E-enriched high density lipoprotein by LDL-apheresis in familial hypercholesterolaemia: a possible activation of the reverse cholesterol transport system.

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1988, Atherosclerosis.

Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2016, Lipids in Health and Disease.

Sex Differences in Associations Among Obesity, Metabolic Abnormalities, and Chronic Kidney Disease in Japanese Men and Women.

H. Mabuchi, J. Kobayashi, H. Nakagawa, 2016, Journal of epidemiology.

Lipid Management in a Japanese Community: Attainment Rate of Target Set by the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012

K. Hayashi, M. Yamagishi, H. Mabuchi, 2017, Journal of atherosclerosis and thrombosis.

The E32K variant of PCSK9 exacerbates the phenotype of familial hypercholesterolaemia by increasing PCSK9 function and concentration in the circulation.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2010, Atherosclerosis.

Association of cholesteryl ester transfer protein activity and TaqIB polymorphism with lipoprotein variations in Japanese subjects.

J. Sasaki, N. Yamada, H. Mabuchi, 2003, Metabolism: clinical and experimental.

Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000.

Y. Ouchi, Y. Matsuzawa, T. Kita, 2005, Journal of atherosclerosis and thrombosis.

Generation and gender differences in the components contributing to the diagnosis of the metabolic syndrome according to the Japanese criteria.

H. Mabuchi, J. Kobayashi, M. Matoba, 2007, Circulation journal : official journal of the Japanese Circulation Society.

Coronary artery bypass grafting in familial hypercholesterolemia.

H. Mabuchi, H. Takemura, M. Kawasuji, 1995, The Journal of thoracic and cardiovascular surgery.

CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2006, Clinical science.

Coronary lesion morphology and prognosis in young males with myocardial infarction with or without familial hypercholesterolemia.

H. Mabuchi, M. Yamaguchi, M. Shimizu, 2001, Japanese circulation journal.

Predictive ability of modified Ottawa score for recurrence in patients with cancer-associated venous thromboembolism: From the COMMAND VTE Registry.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2020, Thrombosis research.

Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism　- From the COMMAND VTE Registry.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2020, Circulation journal : official journal of the Japanese Circulation Society.

Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE Registry.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2019, Thrombosis research.

Cancer-Associated Venous Thromboembolism in the Real World　- From the COMMAND VTE Registry.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2019, Circulation journal : official journal of the Japanese Circulation Society.

Ischemic and Bleeding Events After First Major Bleeding Event in Patients Undergoing Coronary Stent Implantation.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, The American journal of cardiology.

Transcatheter Aortic Valve Implantation vs. Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Real-World Clinical Practice.

M. Toyofuku, C. Izumi, Takeshi Kimura, 2020, Circulation journal : official journal of the Japanese Circulation Society.

Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients with Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From CREDO-Kyoto PCI/CABG Registry Cohort-3).

Takeshi Kimura, T. Morimoto, H. Shiomi, 2021, The American journal of cardiology.

Coronary Revascularization in the Past Two Decades in Japan (From the CREDO-Kyoto PCI/CABG Registries Cohort-1, -2, and -3).

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, The American journal of cardiology.

B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis

M. Toyofuku, C. Izumi, Takeshi Kimura, 2018, Heart.

Impact of bezafibrate and atorvastatin on lipoprotein subclass in patients with type III hyperlipoproteinemia: result from a crossover study.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2011, Clinica chimica acta; international journal of clinical chemistry.

Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy.

M. Motomura, N. Kato, I. Miyamori, 2006, Diabetes care.

Effects of Fenofibrate Therapy on Plasma Ubiquinol‐10 and Ubiquinone‐10 Levels in Japanese Patients with Hyperlipidemia and Type 2 Diabetes Mellitus

H. Mabuchi, J. Kobayashi, A. Nohara, 2006, Pharmacotherapy.

Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study.

H. Mabuchi, J. Kobayashi, A. Nohara, 2007, Atherosclerosis.

Serum lipid survey and its recent trend in the general Japanese population in 2000.

Y. Ouchi, Y. Matsuzawa, T. Kita, 2005, Journal of atherosclerosis and thrombosis.

Clinical effects of rosuvastatin, a new HMG-CoA reductase inhibitor, in Japanese patients with primary hypercholesterolemia: an early phase II study.

Y. Matsuzawa, J. Sasaki, K. Arakawa, 2002, Journal of atherosclerosis and thrombosis.

Additive effects of another kind of HMG-CoA reductase inhibitor with different pharmacokinetics in the treatment of heterozygous familial hypercholesterolemia.

H. Mabuchi, Akihiro Inazu, J. Koizumi, 2000, Atherosclerosis.

Opposite effects on serum cholesteryl ester transfer protein levels between long-term treatments with pravastatin and probucol in patients with primary hypercholesterolemia and xanthoma.

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1999, Atherosclerosis.

Quantification of coronary artery calcification using ultrafast computed tomography: Reproducibility of measurements

H. Mabuchi, K. Kajinami, N. Takekoshi, 1993, Coronary artery disease.

Coronary calcification and coronary atherosclerosis: site by site comparative morphologic study of electron beam computed tomography and coronary angiography.

H. Mabuchi, K. Kajinami, N. Takekoshi, 1997, Journal of the American College of Cardiology.

Abdominal Aortic Aneurysms in Familial Hypercholesterolemia—Case Reports

H. Mabuchi, J. Koizumi, M. Shimizu, 1993, Angiology.

Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia. 1981.

H. Mabuchi, J. Koizumi, T. Wakasugi, 1981, Atherosclerosis. Supplements.

Title In-hospital Outcome in Octogenarians with Acute Coronary SyndromeUndergoing Emergent Coronary Angiography

K. Hayashi, H. Mabuchi, M. Yamaguchi, 2017 .

In-hospital outcome in octogenarians with acute coronary syndrome undergoing emergent coronary angiography.

K. Hayashi, H. Mabuchi, M. Yamaguchi, 2003, Japanese heart journal.

Risk of Colorectal Neoplasm in Patients with Acromegaly and its Relationship with Serum Growth Hormone Levels

A. Suzuki, H. Mabuchi, Y. Takeda, 2005, The American Journal of Gastroenterology.

A deficiency of cholesteryl ester transfer protein whose serum remnant-like particle-triglyceride significantly increased, but serum remnant-like particle-cholesterol did not after an oral fat load

H. Mabuchi, J. Kobayashi, Akihiro Inazu, 2009, Annals of clinical biochemistry.

Association of genetic variation of the adiponectin gene with body fat distribution and carotid atherosclerosis in Japanese obese subjects.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2007, Journal of atherosclerosis and thrombosis.

Association of coronary artery ectasia with plasma insulin levels in Japanese men of heterozygous familial hypercholesterolemia with the low-density lipoprotein receptor gene mutation K790X.

H. Mabuchi, J. Kobayashi, A. Nohara, 2005, Clinica chimica acta; international journal of clinical chemistry.

Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan　- From the CREDO-Kyoto Registry Cohort-2 and Cohort-3.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, Circulation journal : official journal of the Japanese Circulation Society.

Clinical and Electrophysiological Characteristics of Brugada Syndrome Caused by a Missense Mutation in the S5‐Pore Site of SCN5A

K. Imoto, H. Mabuchi, M. Shimizu, 2005, Journal of cardiovascular electrophysiology.

Title Oxidative Stress Correlates with Left Ventricular Volume after AcuteMyocardial Infarction

H. Mabuchi, M. Yamaguchi, M. Shimizu, 2017 .

Oxidative stress correlates with left ventricular volume after acute myocardial infarction.

H. Mabuchi, M. Yamaguchi, M. Shimizu, 2002, Japanese heart journal.

Changes in cardiac tissue characterization in carriers with gene mutations associated with hypertrophic cardiomyopathy.

H. Mabuchi, M. Yamaguchi, M. Shimizu, 2005, International journal of cardiology.

Iatrogenic left coronary artery dissection

H. Mabuchi, M. Yamaguchi, M. Shimizu, 2003, Heart.

Hemodynamic changes and prognosis in patients with hypertrophic cardiomyopathy and abnormal blood pressure responses during exercise

J. Taki, K. Hayashi, H. Mabuchi, 2003, Clinical cardiology.

An 11-year-old boy with familial hypercholesterolemia showing multiple xanthomas and advanced atherosclerosis, who responded to lipid-lowering therapy using statin.

H. Mabuchi, T. Ohta, T. Ohshiro, 2009, Journal of atherosclerosis and thrombosis.

Two novel mutations of PTEN gene in Japanese patients with Cowden syndrome

H. Mabuchi, K. Miwa, T. Okada, 2004, American journal of medical genetics. Part A.

Mutation Analysis of the PTEN/MMAC1 Gene in Japanese Patients with Cowden Disease

H. Mabuchi, T. Okada, T. Sawada, 2000, Japanese journal of cancer research : Gann.

Effect of walking with a pedometer on serum lipid and adiponectin levels in Japanese middle-aged men.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2006, Journal of atherosclerosis and thrombosis.

Assessments of Carotid Artery Plaque Burden in Patients With Familial Hypercholesterolemia.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2017, The American journal of cardiology.

Effects of gender on the number of diseased vessels and clinical outcome in Japanese patients with acute coronary syndrome.

K. Hayashi, H. Mabuchi, M. Yamaguchi, 2002, Circulation journal : official journal of the Japanese Circulation Society.

Lispro is superior to regular insulin in transient intensive insulin therapy in type 2 diabetes.

H. Mabuchi, D. Chujo, K. Yagi, 2004, Internal medicine.

Carotid artery intima‐media thickness and brachial artery flow‐mediated vasodilation in asymptomatic Japanese male subjects amongst apolipoprotein E phenotypes

H. Mabuchi, Akihiro Inazu, T. Wakasugi, 2002, Journal of internal medicine.

A novel method for measuring human hepatic lipase activity in postheparin plasma Published, JLR Papers in Press, November 7, 2006.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2007, Journal of Lipid Research.

Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by Achilles' tendon thickness.

H. Mabuchi, K. Ueda, T. Haba, 1977, Atherosclerosis.

Decreased serum cholesteryl-ester transfer activity in a patient with familial hyper-alpha-lipoproteinemia.

H. Mabuchi, T. Takegoshi, T. Haba, 1988, Clinica chimica acta; international journal of clinical chemistry.

Difference between fasting and nonfasting triglyceridemia; the influence of waist circumference.

M. Yamagishi, K. Miura, H. Mabuchi, 2009, Journal of atherosclerosis and thrombosis.

Cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells to serum is preserved in CETP-deficient patients.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2009, Clinica chimica acta; international journal of clinical chemistry.

Half a Century Tales of Familial Hypercholesterolemia (FH) in Japan

H. Mabuchi, 2017, Journal of atherosclerosis and thrombosis.

Clinical significance of measuring soluble LR11, a circulating marker of atherosclerosis and HbA1c in familial hypercholesterolemia.

H. Mabuchi, H. Tada, J. Kobayashi, 2014, Clinical biochemistry.

Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia

H. Mabuchi, J. Koizumi, K. Kajinami, 1998 .

Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2011, Atherosclerosis.

Coronary ectasia in a homozygous patient with familial hypercholesterolemia.

H. Mabuchi, T. Ikawa, I. Michishita, 1986, Atherosclerosis.

Inhibition effect of quinaldic acid on glucose-induced insulin release from isolated Langerhans islets of the rat.

H. Mabuchi, S. Miyamoto, R. Takeda, 1974, Biochemical and biophysical research communications.

Insulin-releasing effect of quinaldic acid and its relatives on isolated Langerhans islets.

H. Mabuchi, S. Miyamoto, Y. Yoneyama, 1973, Biochemical and biophysical research communications.

Lipoprotein lipase and atherosclerosis

H. Mabuchi, J. Kobayashi, 1998, Annals of clinical biochemistry.

Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis.

H. Mabuchi, J. Kobayashi, A. Nohara, 2005, The Journal of clinical endocrinology and metabolism.

The distribution of fasting and non-fasting serum triglyceride levels in Japanese population.

H. Mabuchi, J. Kobayashi, A. Nohara, 2006, Clinica chimica acta; international journal of clinical chemistry.

Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: results from a crossover study.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2011, Atherosclerosis.

Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.

H. Mabuchi, J. Koizumi, K. Kajinami, 1998, The American journal of cardiology.

Polymorphisms of apolipoprotein e and methylenetetrahydrofolate reductase in the Japanese population.

Y. Ouchi, Y. Matsuzawa, T. Kita, 2007, Journal of atherosclerosis and thrombosis.

Rapid detection and prevalence of cholesteryl ester transfer protein deficiency caused by an intron 14 splicing defect in hyperalphalipoproteinemia

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1993, Human Genetics.

Prevalence of the metabolic syndrome in elderly and middle-aged Japanese

Y. Ouchi, Y. Matsuzawa, T. Kita, 2010 .

Effect of an inhibitor of 3-hydroxy-3-methyglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia.

H. Mabuchi, J. Koizumi, S. Miyamoto, 1981, The New England journal of medicine.

Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency.

A. Tall, H. Mabuchi, P. Moulin, 1991, Atherosclerosis.

Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation. Studies in CETP transgenic mice and human genetic CETP deficiency.

A. Tall, H. Mabuchi, Akihiro Inazu, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Hepatic Lipase: a Comprehensive View of its Role on Plasma Lipid and Lipoprotein Metabolism.

H. Mabuchi, J. Kobayashi, K. Nakajima, 2015, Journal of atherosclerosis and thrombosis.

Remnant-like particles and coronary artery disease in familial hypercholesterolemia.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2018, Clinica chimica acta; international journal of clinical chemistry.

Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease.

M. Yamagishi, H. Mabuchi, A. Tajima, 2018, Journal of clinical lipidology.

Lipoprotein(a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gain-of-Function Mutations.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2016, Circulation journal : official journal of the Japanese Circulation Society.

Clinical characteristics of Japanese patients with severe hypertriglyceridemia.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2015, Journal of clinical lipidology.

Clinical efficacy and safety of rosuvastatin in Japanese patients with heterozygous familial hypercholesterolemia.

H. Mabuchi, A. Nohara, Y. Ikeda, 2004, Journal of atherosclerosis and thrombosis.

Clinical efficacy and safety of cerivastatin in the treatment of heterozygous familial hypercholesterolemia.

H. Mabuchi, J. Koizumi, K. Kajinami, 1998, The American journal of cardiology.

Effects of chronic neutral endopeptidase inhibition in rats with cyclosporine‐induced hypertension

A. Fujimura, I. Miyamori, H. Mabuchi, 2000, Journal of hypertension.

Impact of evolocumab treatment on low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemic patients withdrawing from regular apheresis.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2017, Atherosclerosis.

Analysis of ankyrin-B gene mutations in patients with long QT syndrome.

Xiaoping Zhou, H. Mabuchi, M. Shimizu, 2006, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

Decreased serum cholesteryl-ester transfer activity in a patient with familial hyperalphalipoproteinemia.

H. Mabuchi, T. Takegoshi, T. Haba, 1988, Japanese journal of medicine.

Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.

A. Tall, H. Mabuchi, Akihiro Inazu, 1990, The New England journal of medicine.

Dual effects on HDL metabolism by cholesteryl ester transfer protein inhibition in HepG2 cells.

H. Mabuchi, A. Nohara, M. Kawashiri, 2003, American journal of physiology. Endocrinology and metabolism.

Compound heterozygote of cholesteryl-ester transfer protein deficiency in a patient with hyperalphalipoproteinemia.

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1992, Atherosclerosis.

Molecular mechanism of low density lipoprotein oxidation by 12-lipoxygenase-overexpressing macrophages

H. Mabuchi, Yoshitaka Takahashi, T. Yoshimoto, 2002 .

An unsolved mystery of promoter variation in CETP gene and atherosclerosis

H. Mabuchi, Akihiro Inazu, 2001, European Journal of Clinical Investigation.

Effects of high sodium intake on cardiovascular aldosterone synthesis in stroke-prone spontaneously hypertensive rats

I. Miyamori, H. Mabuchi, M. Demura, 2001, Journal of hypertension.

Extreme Contrast of Postprandial Remnant-Like Particles Formed in Abetalipoproteinemia and Homozygous Familial Hypobetalipoproteinemia.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2015, JIMD reports.

Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2009, Clinica chimica acta; international journal of clinical chemistry.

Postprandial triglyceridaemia in men with impaired fasting glucose, impaired glucose tolerance and diabetes

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2008, Diabetic medicine : a journal of the British Diabetic Association.

Increased circulating matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction.

H. Mabuchi, M. Yamaguchi, A. Nohara, 2004, Circulation journal : official journal of the Japanese Circulation Society.

Enzyme immunoassay for cholesteryl ester transfer protein in human serum.

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1998, Clinica chimica acta; international journal of clinical chemistry.

Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins

A. Tall, Y. Marcel, C. Mann, 1989, Nature.

Double deletions and missense mutations in the first nucleotide-binding fold of the ATP-binding cassette transporter A1 (ABCA1) gene in Japanese patients with Tangier disease

G. Schmitz, H. Mabuchi, Akihiro Inazu, 2002, Journal of Human Genetics.

Clinical utility of the BIWACO score for patients with atrial fibrillation after percutaneous coronary intervention

T. Takeda, H. Mabuchi, Akashi Miyamoto, 2021, Heart and Vessels.

Effects of ML-236 B ( Compactin ) on Sterol Synthesis and Low Density Lipoprotein Receptor Activities in Fibroblasts of Patients with Homozygous Familial Hypercholesterolemia

H. Mabuchi, J. Koizumi, T. Wakasugi, 2013 .

ApoVLDL of the Watanabe Heritable Hyperlipidemic rabbit and the cholesterol-fed rabbit.

Y. Watanabe, H. Mabuchi, J. Koizumi, 1984, Journal of lipid research.

Effects of ML-236b (compactin) on sterol synthesis and low density lipoprotein receptor activities in fibroblasts of patients with homozygous familial hypercholesterolemia.

H. Mabuchi, J. Koizumi, K. Ueda, 1981, The Journal of clinical investigation.

Serum and lipoprotein lipid levels in diabetic patients with familial hypercholesterolemia.

H. Mabuchi, J. Koizumi, T. Haba, 1983, The Tohoku journal of experimental medicine.

A case of heterozygous familial hypercholesterolemia associated with hyperthyroidism: effects of triiodothyronine on low-density lipoprotein receptor and cholesterol synthesis.

H. Mabuchi, J. Koizumi, S. Miyamoto, 1983, Metabolism: clinical and experimental.

A possible translational control of 3-hydroxy-3-methylglutaryl coenzyme A reductase induction by ML-236b(compactin) in isolated rat hepatocytes.

H. Mabuchi, J. Koizumi, R. Takeda, 1982, Biochemical and biophysical research communications.

New Variant of Low Density Lipoprotein Receptor Gene: FH×Tonami

H. Mabuchi, J. Koizumi, T. Wakasugi, 1988, Arteriosclerosis.

A novel method for determining functional LDL receptor activity in familial hypercholesterolemia: application of the CD3/CD28 assay in lymphocytes.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2009, Clinica chimica acta; international journal of clinical chemistry.

Novel gene mutations at the low density lipoprotein receptor locus: FH‐Kanazawa and FH‐Okayama

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1990, Journal of internal medicine.

Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy.

I. Miyamori, H. Mabuchi, M. Demura, 2000, Endocrinology.

Causes of death in patients with familial hypercholesterolemia.

H. Mabuchi, T. Wakasugi, K. Ueda, 1986, Atherosclerosis.

Abetalipoproteinemia caused by maternal isodisomy of chromosome 4q containing an intron 9 splice acceptor mutation in the microsomal triglyceride transfer protein gene.

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Therapy: PCSK9 inhibitors for treating familial hypercholesterolaemia

H. Mabuchi, A. Nohara, 2015, Nature Reviews Endocrinology.

A case of hyperLp(a)aemia, associated with systemic lupus erythematosus, suffering from myocardial infarction and cerebral infarction.

H. Mabuchi, T. Takegoshi, T. Haba, 1990, Japanese journal of medicine.

The expression of steroidogenic enzyme genes in human vascular cells

Hiroshi Yamamoto, I. Miyamori, H. Mabuchi, 1996, Biochemistry and molecular biology international.

Vascular aldosterone in genetically hypertensive rats.

I. Miyamori, H. Mabuchi, Y. Takeda, 1997, Hypertension.

[Alterations of Lp (a) lipoprotein in patients with chronic renal failure treated by continuous ambulatory peritoneal dialysis].

H. Mabuchi, T. Takegoshi, K. Kawai, 1993, Nihon Jinzo Gakkai shi.

A novel type of familial hypercholesterolemia: double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2011, Atherosclerosis.

Association of estrogen receptor-alpha gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia.

H. Mabuchi, A. Nohara, Akihiro Inazu, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Association of Estrogen Receptor-Gene Polymorphisms With Coronary Artery Disease in Patients With Familial Hypercholesterolemia

H. Mabuchi, A. Nohara, Akihiro Inazu, 2002 .

Hyperhomocysteinemia, diabetes mellitus, and carotid atherosclerosis independently increase atherosclerotic vascular disease outcome in Japanese patients with end-stage renal disease.

H. Mabuchi, Akihiro Inazu, J. Koizumi, 2001, Clinical nephrology.

Alterations of lipoprotein(a) in patients with diabetic nephropathy.

H. Mabuchi, T. Takegoshi, T. Haba, 1990, Atherosclerosis.

Clinical outcome after surgical aortic valve replacement in low-risk Japanese patients with severe aortic stenosis

M. Toyofuku, C. Izumi, Takeshi Kimura, 2020, Cardiovascular Intervention and Therapeutics.

Plasma homocysteine level and development of coronary artery disease.

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1999, Coronary artery disease.

Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2014, Atherosclerosis.

Effects of coenzyme Q(10) on LDL oxidation in vitro.

H. Mabuchi, A. Nohara, M. Kawashiri, 2013, Acta medica Iranica.

Difference in coronary blood flow dynamics between patients with hypertension and those with hypertrophic cardiomyopathy.

H. Mabuchi, T. Matsubara, M. Shimizu, 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

Regulation of fatty acid synthesis in isolated hepatocytes by intestinal chylomicrons and their remnants

H. Mabuchi, J. Koizumi, T. Wakasugi, 1979, FEBS letters.

Exercise-induced ST-segment depression and systolic dysfunction in patients with nonobstructive hypertrophic cardiomyopathy.

J. Taki, H. Mabuchi, M. Yamaguchi, 2000, American heart journal.

Penicillin for hypercholesterolemia

H. Mabuchi, 2004 .

Two novel mutations, L490R and V561X, of the transferrin receptor 2 gene in Japanese patients with hemochromatosis.

H. Mabuchi, K. Yoshioka, M. Yano, 2005, Haematologica.

Causes of long-term mortality in patients with venous thromboembolism in the real world: From the COMMAND VTE registry.

M. Toyofuku, T. Morimoto, Takao Kato, 2022, Thrombosis research.

Optimal quality of vitamin K antagonist therapy in Japanese patients with venous thromboembolism.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2022, Journal of cardiology.

Gene mutations in adult Japanese patients with dilated cardiomyopathy.

H. Mabuchi, M. Shimizu, H. Ino, 2005, Circulation journal : official journal of the Japanese Circulation Society.

A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients.

K. Hayashi, H. Mabuchi, M. Yamaguchi, 2003, Journal of the American College of Cardiology.

Cardiac Dysfunction and Long-Term Prognosis in Patients with Nonobstructive Hypertrophic Cardiomyopathy and Abnormal 123I-15- (p-Iodophenyl)-3(R,S)-Methylpentadecanoic Acid Myocardial Scintigraphy

K. Nakajima, J. Taki, H. Mabuchi, 2000, Cardiology.

Lipoprotein metabolism in familial hypercholesterolemia: Serial assessment using a one-step ultracentrifugation method

K. Hayashi, M. Yamagishi, H. Mabuchi, 2015, Practical laboratory medicine.

Infantile Cases of Sitosterolaemia with Novel Mutations in the ABCG5 Gene: Extreme Hypercholesterolaemia is Exacerbated by Breastfeeding.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2015, JIMD reports.

Serum apolipoproteins in heterozygous familial hypercholesterolemia.

H. Mabuchi, J. Koizumi, K. Kajinami, 1992, Clinica chimica acta; international journal of clinical chemistry.

A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency.

H. Mabuchi, J. Koizumi, T. Wakasugi, 1989, Metabolism: clinical and experimental.

Relation between Serum Lipid and Lipoprotein Levels and the Degree of Coronary Artery Sclerosis Studied by Selective Coronary Cine-Angiography

H. Mabuchi, J. Koizumi, T. Wakasugi, 1979 .

Simultaneous, clonally identical T cell expansion in tonsil and synovium in a patient with rheumatoid arthritis and chronic tonsillitis.

M. Kawano, H. Mabuchi, A. Yachie, 2003, Arthritis and rheumatism.

Absence of CD69 expression on peripheral eosinophils in episodic angioedema and eosinophilia

T. Miyawaki, M. Kawano, H. Mabuchi, 1996, American journal of hematology.

Cardiac Aldosterone Production in Genetically Hypertensive Rats

I. Miyamori, H. Mabuchi, M. Demura, 2000, Hypertension.

Enhanced Cholesteryl Ester Transfer Protein Activities and Abnormalities of High Density Lipoproteins in Familial Hypercholesterolemia

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1992, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Increased QT dispersion does not reflect the increased regional variation of cardiac sympathetic nervous activity in hypertrophic cardiomyopathy.

K. Nakajima, J. Taki, H. Mabuchi, 2001, American heart journal.

A Novel Missense Mutation in the SCN5A Gene Associated with Brugada Syndrome Bidirectionally Affecting Blocking Actions of Antiarrhythmic Drugs

K. Imoto, H. Mabuchi, S. Takata, 2005, Journal of cardiovascular electrophysiology.

High Incidence of Sudden Cardiac Death With Conduction Disturbances and Atrial Cardiomyopathy Caused by a Nonsense Mutation in the STA Gene

K. Hayashi, H. Mabuchi, M. Yamaguchi, 2005, Circulation.

Differentiation between patients with takotsubo cardiomyopathy and those with anterior acute myocardial infarction.

H. Mabuchi, M. Yamaguchi, M. Shimizu, 2005, Circulation journal : official journal of the Japanese Circulation Society.

Effect of FK 506 on the Expression of Endothelin Receptor mRNA in the Vasculature

I. Miyamori, H. Mabuchi, Y. Takeda, 1995, Journal of Cardiovascular Pharmacology.

[Selective hypoaldosteronism with hyperreninemia in a diabetic patient (author's transl)].

I. Miyamori, H. Mabuchi, K. Uchida, 1978, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Comparative Effects of Dietary Fat Types on Hepatic Enzyme Activities Related to the Synthesis and Oxidation of Fatty Acid and to Lipogenesis in Rats

H. Mabuchi, M. Kawakami, Y. Mori, 2001, Bioscience, biotechnology, and biochemistry.

A novel mutation in the cardiac myosin-binding protein C gene is responsible for hypertrophic cardiomyopathy with severe ventricular hypertrophy and sudden death.

H. Mabuchi, M. Shimizu, H. Ino, 2006, Clinical science.

A family of familial hypercholesterolemia with cerebral infarction and without coronary heart disease An unusual case with corneal opacity, polyneuropathy and carpal tunnel syndrome in the family: Therapy with probucol and tocopherol nicotinate

H. Mabuchi, K. Kajinami, M. Kibata, 1991, Journal of the Neurological Sciences.

Identical twins with long QT syndrome associated with a missense mutation in the S4 region of the HERG.

H. Mabuchi, M. Shimizu, H. Ino, 2000, Japanese heart journal.

Detailed analysis of serum lipids and lipoproteins from Japanese type III hyperlipoproteinemia with apolipoprotein E2/2 phenotype.

H. Mabuchi, J. Kobayashi, A. Nohara, 2004, Clinica chimica acta; international journal of clinical chemistry.

Lecithin: cholesterol acyl transfer rate in hypothyroidism and hyperthyroidism.

H. Mabuchi, J. Koizumi, S. Miyamoto, 1982, Endocrinologia japonica.

Mechanisms of FK 506-induced hypertension in the rat.

I. Miyamori, H. Mabuchi, Y. Takeda, 1999, Hypertension.

Atrial fibrillation in patients with severe aortic stenosis.

M. Toyofuku, C. Izumi, Takeshi Kimura, 2022, Journal of cardiology.

Clinical features of prognosis of Japanese patients with anomalous origin of the coronary artery.

H. Mabuchi, M. Shimizu, H. Ino, 1996, Japanese circulation journal.

Lipoprotein metabolism in pregnancy, fat transport to the fetus, and the effects of diabetes.

H. Mabuchi, M. V. Van Allen, M. Childs, 1986, Biology of the neonate.

Completely skewed X-inactivation in a mentally retarded young female with pseudohypoparathyroidism type IB and juvenile renin-dependent hypertension.

H. Mabuchi, M. Demura, Y. Takeda, 2003, The Journal of clinical endocrinology and metabolism.

Arrhythmias in patients with Brugada-type electrocardiographic findings.

H. Mabuchi, M. Yamaguchi, M. Shimizu, 2001, Japanese circulation journal.

Propranolol for probucol-induced QT prolongation with polymorphic ventricular tachycardia

H. Mabuchi, K. Kajinami, N. Takekoshi, 1993, The Lancet.

Comparison of the effects of losartan vs. ramipril on several adipocytokines and vascular remodeling biomarkers

H. Mabuchi, J. Kobayashi, A. Nohara, 2011, Hypertension Research.

Low-density lipoprotein receptor genotype-dependent response to cholesterol lowering by combined pravastatin and cholestyramine in familial hypercholesterolemia.

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1998, The American journal of cardiology.

Genetic analysis of the cytochrome P‐450c17α (CYP17) and aldosterone synthase (CYP11B2) in Japanese patients with 17α‐hydroxylase deficiency

I. Miyamori, H. Mabuchi, M. Demura, 2001, Clinical endocrinology.

A possible new syndrome with double endocrine tumors in association with an unprecedented type of familial heart-hand syndrome: a case report

M. Kawano, M. Yamagishi, H. Mabuchi, 2010, Journal of medical case reports.

Collagen remodeling and cardiac dysfunction in patients with hypertrophic cardiomyopathy: The significance of type III and VI collagens

H. Mabuchi, M. Yamaguchi, M. Shimizu, 2001, Clinical cardiology.

The incidence and pathogenesis of hyperlipidaemia in 16 consecutive acromegalic patients.

H. Mabuchi, K. Ueda, H. Nakabayashi, 1982, Acta endocrinologica.

Autopsy findings in siblings with hypertrophic cardiomyopathy caused by Arg92Trp mutation in the cardiac troponin T gene showing dilated cardiomyopathy‐like features

H. Mabuchi, M. Yamaguchi, A. Kawashima, 2003, Clinical cardiology.

Inhibition by somatostatin of insulin release from isolated pancreatic islets

H. Mabuchi, S. Miyamoto, R. Takeda, 1975, FEBS letters.

19-Noraldosterone in pregnancy-induced hypertension

H. Mabuchi, M. Demura, Y. Takeda, 2002, Steroids.

Identification of a novel missense mutation in the sterol 27-hydroxylase gene in two Japanese patients with cerebrotendinous xanthomatosis.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2010, Internal medicine.

A study of the clinical significance of lipoprotein (a) in nephrotic syndrome.

H. Mabuchi, T. Wakasugi, T. Takegoshi, 1991, Japanese Journal of Medicine.

Title Heterogeneity of cardiac sympathetic nerve activity and systolicdysfunction in patients with hypertrophic cardiomyopathy

K. Nakajima, J. Taki, K. Hayashi, 2017 .

Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy.

K. Nakajima, J. Taki, K. Hayashi, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Cardiac sympathetic activity in the asymmetrically hypertrophied septum in patients with hypertension or hypertrophic cardiomyopathy

K. Nakajima, J. Taki, H. Mabuchi, 2000, Clinical cardiology.

Clinical characteristics of polycystic kidney disease with end-stage renal disease. The Kanazawa Renal Disease Study Group.

H. Mabuchi, T. Konoshita, K. Okamoto, 1998, Clinical nephrology.

Postprandial lipoprotein metabolism: VLDL vs chylomicrons.

H. Mabuchi, J. Kobayashi, Akihiro Inazu, 2011, Clinica chimica acta; international journal of clinical chemistry.

Decreased post-prandial triglyceride response and diminished remnant lipoprotein formation in cholesteryl ester transfer protein (CETP) deficiency.

H. Mabuchi, J. Kobayashi, A. Nohara, 2008, Atherosclerosis.

Collagen synthesis by cultured cardiac fibroblasts obtained from cardiomyopathic hamsters.

H. Mabuchi, M. Shimizu, H. Ino, 1998, Japanese heart journal.

Effects of angiotensin-converting enzyme inhibitor and aldosterone antagonist on myocardial collagen in cardiomyopathic hamsters.

H. Mabuchi, M. Shimizu, H. Ino, 1995, Japanese circulation journal.

Autosomal recessive hypercholesterolemia: a mild phenotype of familial hypercholesterolemia: insight from the kinetic study using stable isotope and animal studies.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2015, Journal of atherosclerosis and thrombosis.

A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy.

H. Mabuchi, M. Yamaguchi, M. Shimizu, 2002, The American journal of cardiology.

Right ventricular metastasis from a primary cervical carcinoma.

H. Mabuchi, M. Shimizu, H. Kanaya, 2001, Japanese circulation journal.

Quantitative evaluation of the rate of myocardial interstitial fibrosis using a personal computer.

H. Mabuchi, Y. Kita, M. Shimizu, 1997, Japanese circulation journal.

Quantitative assessment of diffuse coronary artery disease using a three‐dimensional reconstruction method compared with intravascular ultrasound images

H. Mabuchi, M. Shimizu, H. Ino, 2001, Coronary artery disease.

Low‐density Lipoprotein Apheresis Therapy With a Direct Hemoperfusion Column: A Japanese Multicenter Clinical Trial

M. Matsuzaki, H. Daida, K. Yamashita, 2006, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Long‐term Effect of Low‐density Lipoprotein Apheresis in Patients with Heterozygous Familial Hypercholesterolemia

H. Mabuchi, T. Higashikata, 2003, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Therapeutic effects of LDL apheresis in the prevention of atherosclerosis.

H. Mabuchi, K. Kajinami, Hiroshi Mabuchi, 1999, Current opinion in lipidology.

Effects of CS-514 (eptastatin), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, on serum lipid and apolipoprotein levels in heterozygous familial hypercholesterolemic patients treated by low density lipoprotein (LDL)-apheresis.

H. Mabuchi, J. Koizumi, K. Kajinami, 1988, Atherosclerosis.

Absence of familial defective apolipoprotein B-100 in Japanese patients with familial hypercholesterolaemia

H. Mabuchi, A. Nohara, Akihiro Inazu, 1995, The Lancet.

Up-Regulation of cyr61 in Vascular Smooth Muscle Cells of Spontaneously Hypertensive Rats

Hiroshi Yamamoto, H. Mabuchi, Y. Ueda, 2003, Laboratory Investigation.

Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism.

I. Miyamori, H. Mabuchi, Y. Takeda, 1999, The Journal of clinical endocrinology and metabolism.

Running title: Stitziel et al., Exome Sequencing in Monogenic Dyslipidemias

S. Gabriel, M. Daly, D. Nickerson, 2015 .

Long-term efficacy of immunoadsorbent plasmapheresis in a patient with Budd-Chiari syndrome due to antiphospholipid syndrome: case report with nine-year follow-up

M. Kawano, H. Mabuchi, K. Ueda, 2004, Lupus.

Post-prandial Remnant Lipoprotein Metabolism in Sitosterolemia

M. Yamagishi, H. Mabuchi, A. Nohara, 2018, Journal of atherosclerosis and thrombosis.

Marked transient hypercholesterolemia caused by low-dose mitotane as adjuvant chemotherapy for adrenocortical carcinoma.

M. Yamagishi, H. Mabuchi, A. Nohara, 2014, Journal of atherosclerosis and thrombosis.

Post‐prandial remnant lipoprotein metabolism in autosomal recessive hypercholesterolaemia

K. Hayashi, M. Yamagishi, H. Mabuchi, 2012, European journal of clinical investigation.

Altered Metabolism of Low-Density Lipoprotein and Very-Low-Density Lipoprotein Remnant in Autosomal Recessive Hypercholesterolemia: Results From Stable Isotope Kinetic Study In Vivo

K. Hayashi, M. Yamagishi, H. Mabuchi, 2012, Circulation. Cardiovascular genetics.

Mutations in the Low Density Lipoprotein Receptor Gene in Japanese Patients with Familial Hypercholesterolemia

H. Mabuchi, J. Koizumi, K. Kajinami, 1990, Annals of the New York Academy of Sciences.

[A case of chylomicronemia with chronic relapsing pancreatitis (author's transl)].

H. Mabuchi, T. Nakai, R. Takeda, 1974, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Detection of diaphragmatic defect as the cause of severe hepatic hydrothorax with magnetic resonance imaging

H. Mabuchi, Syuichi Murata, T. Zenda, 1998, American Journal of Gastroenterology.

Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults.

S. Yamashita, J. Sasaki, N. Yamada, 2002, Journal of atherosclerosis and thrombosis.

Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia.

H. Mabuchi, M. Kawashiri, T. Higashikata, 2004, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Coronary ectasia in familial hypercholesterolemia: histopathologic study regarding matrix metalloproteinases.

H. Mabuchi, J. Koizumi, Y. Oda, 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Clinical and electrophysiological characterization of a novel mutation (F193L) in the KCNQ1 gene associated with long QT syndrome.

K. Hayashi, H. Higashida, H. Mabuchi, 2002, Clinical science.

Syntheses of fused heterocyclic compounds and their inhibitory activities for squalene synthase.

A. Fujishima, H. Mabuchi, M. Kori, 2002, Bioorganic & Medicinal Chemistry.

Successful Surgery of Right Common Iliac Artery Injury during Lumbar Discectomy with Endovascular Balloon Occlusion of the Aorta Performed by Cardiologists

T. Takeda, H. Mabuchi, T. Sakaguchi, 2019, Annals of vascular diseases.

Novel 4,1-benzoxazepine derivatives with potent squalene synthase inhibitory activities.

H. Mabuchi, H. Banno, M. Kori, 2002, Bioorganic & medicinal chemistry.

Cholesteryl ester transfer protein and atherosclerosis

H. Mabuchi, Akihiro Inazu, J. Koizumi, 2000, Current opinion in lipidology.

Angiotensin Converting Enzyme Inhibitors Are Associated with the Need for Increased Recombinant Human Erythropoietin Maintenance Doses in Hemodialysis Patients

H. Mabuchi, M. Matsumura, H. Nomura, 1997 .

Fatal cardiac beta2-microglobulin amyloidosis in patients on long-term hemodialysis.

M. Kawano, H. Mabuchi, M. Yamada, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Normalization of low-density lipoprotein levels and disappearance of xanthomas during pregnancy in a woman with heterozygous familial hypercholesterolemia.

H. Mabuchi, J. Koizumi, T. Haba, 1985, Metabolism: clinical and experimental.

Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.

H. Mabuchi, J. Koizumi, H Mabuchi, 1983, The New England journal of medicine.

Clinical whole exome sequencing in severe hypertriglyceridemia.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2019, Clinica chimica acta; international journal of clinical chemistry.

Sitosterolemia, Hypercholesterolemia, and Coronary Artery Disease

H. Mabuchi, A. Nohara, M. Kawashiri, 2018, Journal of atherosclerosis and thrombosis.

PRKAR1A gene mutation in patients with cardiac myxoma.

H. Mabuchi, M. Shimizu, H. Ino, 2005, International journal of cardiology.

Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2016, Lipids in Health and Disease.

Exome Sequencing in Suspected Monogenic Dyslipidemias

Rahul C. Deo, S. Gabriel, M. Daly, 2015, Circulation. Cardiovascular genetics.

Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia

M. Yamagishi, H. Mabuchi, A. Nohara, 2017, European heart journal.

Cholesteryl Ester Transfer Protein (CETP) Deficiency and CETP Inhibitors

H. Mabuchi, A. Nohara, Akihiro Inazu, 2014, Molecules and cells.

Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome.

M. Yamagishi, H. Mabuchi, H. Tanii, 2008, Diabetes research and clinical practice.

The first reported case of spotted fever in Fukui Prefecture, the northern part of central Japan.

N. Takada, H. Mabuchi, Y. Noji, 2005, Japanese journal of infectious diseases.

Irrigation of liver abscess: proposal of a novel method and possible indications.

H. Mabuchi, H. Sato, T. Zenda, 2001, Hepato-gastroenterology.

A de novo mutation of the LDL receptor gene as the cause of familial hypercholesterolemia identified using whole exome sequencing.

K. Hayashi, H. Mabuchi, A. Tajima, 2016, Clinica chimica acta; international journal of clinical chemistry.

Gender difference in coronary events in relation to risk factors in Japanese hypercholesterolemic patients treated with low-dose simvastatin.

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2006, Circulation journal : official journal of the Japanese Circulation Society.

Hereditary angioedema complicated with chronic renal failure: report of sibling cases.

H. Mabuchi, H. Nomura, Y. Tofuku, 1992, Internal medicine.

Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients.

H. Mabuchi, M. Matsumura, H. Muramoto, 1996, Nephron.

Sixteen-slice computed tomography, transthoracic real-time 3-dimensional echocardiography and magnetic resonance imaging assessment of a long-term survivor of rupture of sinus of valsalva aneurysm.

H. Mabuchi, Y. Noji, K. Miwa, 2005, Internal medicine.

Cavernous haemangioma in the coronary sinus

H. Mabuchi, M. Yamaguchi, M. Shimizu, 1998, Heart.

A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis).

H. Mabuchi, J. Koizumi, I. Michishita, 1987, Atherosclerosis.

Pathophysiological Roles of the Adrenal Renin-Angiotensin System in Patients with Primary Aldosteronism

H. Mabuchi, Y. Takeda, T. Yoneda, 2006, Hypertension Research.

Identification of two novel missense mutations (p.R1221C and p.R1357W) in the ABCC6 (MRP6) gene in a Japanese patient with pseudoxanthoma elasticum (PXE).

H. Mabuchi, A. Nohara, M. Kawashiri, 2004, Internal medicine.

Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy.

J Taki, M Shimizu, J. Taki, 2000, Journal of the American College of Cardiology.

Asymptomatic versus Symptomatic Patients with Severe Aortic Stenosis

M. Toyofuku, C. Izumi, Takeshi Kimura, 2018, Scientific Reports.

Calcineurin Inhibition Attenuates Mineralocorticoid-Induced Cardiac Hypertrophy

H. Mabuchi, M. Demura, Y. Takeda, 2002, Circulation.

Plasma brain natriuretic peptide level in older outpatients with heart failure is associated with physical frailty, especially with the slowness domain

S. Nishiguchi, H. Mabuchi, T. Aoyama, 2016, Journal of geriatric cardiology : JGC.

Remnant lipoproteins and atherosclerotic cardiovascular disease.

H. Mabuchi, A. Nohara, M. Kawashiri, 2019, Clinica chimica acta; international journal of clinical chemistry.

Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia.

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2002, Circulation journal : official journal of the Japanese Circulation Society.

Cardiac troponin T Arg92Trp mutation and progression from hypertrophic to dilated cardiomyopathy

H. Mabuchi, M. Yamaguchi, M. Shimizu, 2001, Clinical cardiology.

Chronologic electrocardiographic changes in patients with hypertrophic cardiomyopathy associated with cardiac troponin 1 mutation.

K. Hayashi, H. Mabuchi, M. Yamaguchi, 2002, American heart journal.

High Frequency of a Retinoid X Receptor &ggr; Gene Variant in Familial Combined Hyperlipidemia That Associates With Atherogenic Dyslipidemia

Masayuki Tsuchida, Kenji Miwa, Shoji Katsuda, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Catalytically inactive lecithin: cholesterol acyltransferase (LCAT) caused by a Gly 30 to Ser mutation in a family with LCAT deficiency.

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1997, Journal of lipid research.

Association of Angiopoietin-like Protein3 (angptl3) with Htgl and Lpl Activities in Human Plasma

Takeaki, H. Mabuchi, J. Kobayashi, 2022 .

Clinical characteristics of double heterozygotes with familial hypercholesterolemia and cholesteryl ester transfer protein deficiency.

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1997, Atherosclerosis.

Treatment of Congenital Nephrogenic Diabetes insipidus with Hydrochlorothiazide and Amiloride in an Adult Patient

I. Miyamori, H. Mabuchi, Y. Tofuku, 2004, Hormone Research in Paediatrics.

Two novel types of contiguous gene deletion of the AVPR2 and ARHGAP4 genes in unrelated Japanese kindreds with nephrogenic diabetes insipidus

H. Mabuchi, M. Demura, Y. Takeda, 2002, Human mutation.

Severe gastrointestinal complications of dialysis-related amyloidosis in two patients on long-term hemodialysis.

H. Mabuchi, Y. Mizukami, H. Muramoto, 1996, American journal of nephrology.

Decreased expression of 20‐kD homologous restriction factor (HRF20, CD59) on T lymphocytes in Epstein–Barr virus (EBV)‐induced infectious mononucleosis

M. Kawano, H. Mabuchi, A. Yachie, 1997, Clinical and experimental immunology.

Efficacy of Endoscopic Esophageal Variceal Ligation in an Immunocompromised Host

H. Mabuchi, T. Masunaga, Y. Takeda, 1996 .

Coenzyme Q10 Reduction with Statins: Another Pleiotropic Effect

H. Mabuchi, J. Kobayashi, M. Kawashiri, 2007 .

Serum lipids and coronary heart disease in heterozygous familial hypercholesterolemia in the Hokuriku District of Japan.

H. Mabuchi, J. Koizumi, K. Ueda, 1977, Atherosclerosis.

Life style and cardiovascular risk factors in the Japanese population--from an epidemiological survey on serum lipid levels in Japan 1990 part 1: influence of life style and excess body weight on HDL-cholesterol and other lipid parameters in men.

Toru Kita, Yasushi Saito, Y. Matsuzawa, 2003, Journal of atherosclerosis and thrombosis.

Serum lipids, lipoprotein lipids and coronary heart disease in patients with xanthelasma palpebrarum.

H. Mabuchi, J. Koizumi, K. Ueda, 1981, Atherosclerosis.

Effect of Glycemic Control During Follow-up on Late Target Lesion Revascularization After Implantation of New-Generation Drug-Eluting Stents in Patients With Diabetes　― A Single-Center Observational Study ―

Takeshi Kimura, T. Morimoto, T. Takeda, 2020, Circulation reports.

Japan Atherosclerosis Society (JAS) guidelines for diagnosis and treatment of atherosclerotic cardiovascular diseases

H. Mabuchi, 2004 .

Perfusable tissue index obtained by positron emission tomography as a marker of myocardial viability in patients with ischemic ventricular dysfunction.

T. Asai, H. Mabuchi, H. Seki, 2002, Circulation journal : official journal of the Japanese Circulation Society.

Effect of pravastatin-induced LDL-cholesterol reduction on coronary heart disease and cerebrovascular disease in Japanese: Hokuriku lipid coronary heart disease study-pravastatin atherosclerosis trial (Holicos-PAT).

H. Mabuchi, J. Koizumi, S. Miyamoto, 2002, Journal of atherosclerosis and thrombosis.

Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency Published, JLR Papers in Press, December 1, 2003. DOI 10.1194/jlr.M300198-JLR200

E. Schaefer, H. Mabuchi, Akihiro Inazu, 2004, Journal of Lipid Research.

Human Cholesteryl Ester Transfer Protein in Human HDL Metabolism

H. Mabuchi, Akihiro Inazu, 2010 .

Achilles tendon thickness and ischemic heart disease in familial hypercholesterolemia.

H. Mabuchi, K. Ueda, S. Miyamoto, 1978, Metabolism: clinical and experimental.

Effect of L-Carnitine and Palmitoyl-L-Carnitine on Erythroid Colony Formation in Fetal Mouse Liver Cell Culture

H. Mabuchi, M. Matsumura, I. Koni, 1998, American Journal of Nephrology.

Prevalence, clinical features, and prognosis of patients with extremely low high-density lipoprotein cholesterol.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2016, Journal of clinical lipidology.

Whole exome sequencing combined with integrated variant annotation prediction identifies asymptomatic Tangier disease with compound heterozygous mutations in ABCA1 gene.

K. Hayashi, M. Yamagishi, Reina Saito, 2015, Atherosclerosis.

Treatment of homozygous patients with familial hypercholesterolemia by double-filtration plasmapheresis.

H. Mabuchi, T. Wakasugi, I. Michishita, 1986, Atherosclerosis.

Concomitant Mitral Regurgitation in Severe Aortic Stenosis

M. Toyofuku, C. Izumi, Takeshi Kimura, 2021 .

Diagnostic value of abnormal Q waves for identification of preclinical carriers of hypertrophic cardiomyopathy based on a molecular genetic diagnosis.

Masami Shimizu, H. Mabuchi, M. Yamaguchi, 2004, European heart journal.

Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy.

K. Nakajima, J. Taki, H. Mabuchi, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Impacts of Visceral Adipose Tissue and Subcutaneous Adipose Tissue on Metabolic Risk Factors in Middle‐aged Japanese

Yoshiyu Takeda, Kunimasa Yagi, M. Yamagishi, 2010, Obesity.

The Risk of Cardiovascular Events in Japanese Hypertensive Patients with Hypercholesterolemia: Sub-Analysis of the Japan Lipid Intervention Trial (J-LIT) Study, a Large-Scale Observational Cohort Study

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2005, Hypertension Research.

Association of LMNA 1908C/T polymorphism with cerebral vascular disease and diabetic nephropathy in Japanese men with type 2 diabetes

H. Mabuchi, J. Kobayashi, Y. Murase, 2005, Clinical endocrinology.

Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT).

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2005, Circulation journal : official journal of the Japanese Circulation Society.

Obesity as a risk factor for coronary events in Japanese patients with hypercholesterolemia on low-dose simvastatin therapy.

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2010, Journal of atherosclerosis and thrombosis.

AKIRA ENDO: THE DISCOVERY OF STATINS

H. Mabuchi, G. Thompson, 2014 .

Prevalence of metabolic syndrome in the general Japanese population in 2000.

Y. Ouchi, Y. Matsuzawa, T. Kita, 2006, Journal of atherosclerosis and thrombosis.

Risk factors for coronary heart disease in the Japanese--comparison of the background of patients with acute coronary syndrome in the ASPAC study with data obtained from the general population. Asia-Pacific Collaboration on CHD Risk Factor Intervention study.

S. Hosoda, A. Keech, M. Nobuyoshi, 2002, Journal of atherosclerosis and thrombosis.

Clinical characteristics and outcomes of patients with venous thromboembolism according to diagnosis on weekends versus on weekdays

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2020, Journal of Thrombosis and Thrombolysis.

Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin.

I. Miyamori, H. Mabuchi, Y. Takeda, 1996, The Journal of clinical endocrinology and metabolism.

Prognostic Impact of Peak Aortic Jet Velocity in Conservatively Managed Patients With Severe Aortic Stenosis: An Observation From the CURRENT AS Registry

M. Toyofuku, C. Izumi, Takeshi Kimura, 2017, Journal of the American Heart Association.

Life style and cardiovascular risk factors in the Japanese population--from an epidemiological survey on serum lipid levels in Japan 1990 part 2: association of lipid parameters with hypertension.

Y. Matsuzawa, T. Kita, H. Mabuchi, 2003, Journal of atherosclerosis and thrombosis.

Sarcopenia Predicts Adverse Outcomes in an Elderly Outpatient Population with New York Heart Association Class II–IV Heart Failure: A Prospective Cohort Study

S. Nishiguchi, H. Mabuchi, T. Aoyama, 2019, Aging Medicine and Healthcare.

M. Toyofuku, C. Izumi, Takeshi Kimura, 2019, Circulation journal : official journal of the Japanese Circulation Society.

Acute urinary retention as an unusual manifestation of aseptic meningitis.

H. Mabuchi, T. Okada, T. Zenda, 2002, Internal medicine.

Homozygous familial hypercholesterolemia in Japan.

H. Mabuchi, J. Koizumi, K. Ueda, 1978, The American journal of medicine.

NK-104: a novel synthetic HMG-CoA reductase inhibitor

H. Mabuchi, K. Kajinami, Y. Saito, 2000, Expert opinion on investigational drugs.

Comparison of Effects of Pitavastatin and Atorvastatin on Plasma Coenzyme Q10 in Heterozygous Familial Hypercholesterolemia: Results From a Crossover Study

M. Yamagishi, H. Mabuchi, H. Tada, 2008, Clinical pharmacology and therapeutics.

The relationship of percent body fat by bioelectrical impedance analysis with blood pressure, and glucose and lipid parameters.

H. Mabuchi, J. Kobayashi, A. Nohara, 2006, Journal of atherosclerosis and thrombosis.

Molecular Genetics of Cholesterol Transport and Cholesterol Reverse Transport Disorders, and Coronary Heart Disease

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1996 .

Molecular Genetics of Cholesterol Transport and Cholesterol Reverse Transport Disorders (Familial Hypercholesterolemia and CETP Deficiency) and Coronary Heart Disease

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1994 .

Efficacy and safety of coadministration of rosuvastatin, ezetimibe, and colestimide in heterozygous familial hypercholesterolemia.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2012, The American journal of cardiology.

Association of angiopoietin-like protein 3 with hepatic triglyceride lipase and lipoprotein lipase activities in human plasma

H. Mabuchi, J. Kobayashi, K. Nakajima, 2010, Annals of clinical biochemistry.

Relationship of Lipoprotein Lipase and Hepatic Triacylglycerol Lipase Activity to Serum Adiponectin Levels in Japanese Hyperlipidemic Men

H. Mabuchi, J. Kobayashi, Akihiro Inazu, 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene.

H. Mabuchi, M. Yamaguchi, M. Shimizu, 2000, Circulation.

Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese.

H. Iso, T. Okamura, H. Mabuchi, 2002, Atherosclerosis.

Images in cardiology. Non-invasive detection of quadricuspid aortic valve.

H. Mabuchi, N. Takekoshi, K. Kajinami, 1997, Heart.

Prognostic Impact of Aortic Valve Area in Conservatively Managed Patients With Asymptomatic Severe Aortic Stenosis With Preserved Ejection Fraction

M. Toyofuku, M. Onoe, C. Izumi, 2019, Journal of the American Heart Association.

Brain nitric oxide synthase messenger RNA in central mineralocorticoid hypertension.

I. Miyamori, H. Mabuchi, Y. Takeda, 1997, Hypertension.

Effect of adrenocorticotropin stimulation on the synthesis of 19-noraldosterone in man.

I. Miyamori, H. Mabuchi, Y. Takeda, 1996, The Journal of clinical endocrinology and metabolism.

[Changes in serum malondialdehyde-modified low-density lipoprotein in patients with acute myocardial infarction and stable angina pectoris treated by coronary angioplasty].

H. Mabuchi, N. Takekoshi, M. Shimizu, 2001, Journal of cardiology.

A Rare Coincidence of Sitosterolemia and Familial Mediterranean Fever Identified by Whole Exome Sequencing.

K. Hayashi, M. Yamagishi, Y. Toyoshima, 2016, Journal of atherosclerosis and thrombosis.

Reduction of hemolysis without reoperation following mitral valve repair.

H. Mabuchi, M. Shimizu, Mikio Ueda, 2003, Circulation journal : official journal of the Japanese Circulation Society.

Coronary Artery Disease Without Standard Cardiovascular Risk Factors.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, The American journal of cardiology.

Usefulness of Simplified Pulmonary Embolism Severity Index Score for Identification of Patients With Low-Risk Pulmonary Embolism and Active Cancer

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2020 .

Utility of simplified PESI score for identification of low-risk pulmonary embolism patients with active cancer: From the COMMAND VTE Registry.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2019, Chest.

Reasons for Choosing Conservative Management in Symptomatic Patients With Severe Aortic Stenosis　- Observations From the CURRENT AS Registry.

M. Toyofuku, C. Izumi, Takeshi Kimura, 2019, Circulation journal : official journal of the Japanese Circulation Society.

Acute increases in plasma oxidized low-density lipoprotein immediately after percutaneous transluminal coronary angioplasty.

H. Mabuchi, M. Shimizu, H. Ino, 2001, The American journal of cardiology.

Ultrafast computed tomography in the diagnosis and evaluation of anomalous origin of the right coronary artery.

H. Mabuchi, K. Kajinami, H. Ino, 1995, Japanese heart journal.

P-214 Clinical Impact of Heterozygous Carrier of Autosomal Recessive Hypercholesterolemia on Asymptomatic Hyperlipidemic Patients

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2009 .

Abstract 1921: Clinical Impact of Heterozygous Carrier of Autosomal Recessive Hypercholesterolemia on Asymptomatic Hyperlipidemic Patients: Evidence From Familial Gene Analysis

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2008 .

Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization

M. Toyofuku, M. Onoe, Y. Kihara, 2022, JACC. Asia.

Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III

H. Mabuchi, K. To, N. Tang, 2002, Journal of Human Genetics.

Status of lipid-lowering therapy prescribedbased on recommendations in the 2002 report of the Japan Atherosclerosis Society Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults: A study of the Japan Lipid Assessment Program (J-LAP).

A. Kashiwagi, H. Mabuchi, T. Teramoto, 2005, Current therapeutic research, clinical and experimental.

Formation of prebeta1-HDL during lipolysis of triglyceride-rich lipoprotein.

Atsuo Mori, M. Yamagishi, H. Mabuchi, 2009, Biochemical and biophysical research communications.

Assessment of coronary atherosclerosis in patients with familial hypercholesterolemia by coronary computed tomography angiography.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2015, The American journal of cardiology.

Lipoprotein Apheresis for Sitosterolemia

H. Mabuchi, H. Tada, H. Kasuga, 2017, Annals of Internal Medicine.

Title Assessment of Coronary atherosclerosis in patients with familialhypercholesterolemia by coronary computed tomography angiography

K. Hayashi, M. Yamagishi, H. Mabuchi, 2017 .

A case of portal vein thrombosis. Bacteroidal pylethrombosis and changing clinical pictures.

Y. Nakanuma, H. Mabuchi, A. Nonomura, 1997 .

Assessment of arterial stiffness in patients with familial hypercholesterolemia.

M. Yamagishi, H. Mabuchi, A. Nohara, 2017, Journal of clinical lipidology.

Abnormal sympathetic innervation of the heart in a patient with Emery-Dreifuss muscular dystrophy

H. Mabuchi, M. Shimizu, K. Sakata, 2005, Annals of nuclear medicine.

1,5-Benzoxathiepin derivatives. I. Synthesis and reaction of 1,5-benzoxathiepin derivatives.

H. Mabuchi, Y. Kawamatsu, H. Sugihara, 1987, Chemical and pharmaceutical bulletin.

1,5-Benzoxathiepin Derivatives. Part 1. Synthesis and Reaction of 1,5-Benzoxathiepin Derivatives.

H. Mabuchi, Y. Kawamatsu, H. Sugihara, 1987 .

Nephrotic syndrome due to focal glomerulosclerosis and undifferentiated carcinoma.

H. Mabuchi, Y. Tofuku, T. Konoshita, 2000, Clinical nephrology.

Diagnostic usefulness of the post-exercise systolic blood pressure response for the detection of coronary artery disease in patients with diabetes mellitus.

H. Mabuchi, M. Yamaguchi, M. Shimizu, 2000, Japanese circulation journal.

[Dyslipidemia in insulin resistance and its improvement by troglitazone].

H. Mabuchi, K. Yagi, 2000, Nihon rinsho. Japanese journal of clinical medicine.

Surgical stress‐induced transient nephrogenic diabetes insipidus (NDI) associated with decreased Vasopressin receptor2 (AVPR2) expression linked to nonsense‐mediated mRNA decay and incomplete skewed X‐inactivation in a female patient with a heterozygous AVPR2 mutation (c. 89–90 delAC)

H. Mabuchi, Y. Bando, M. Demura, 2004, Clinical endocrinology.

The expression of messenger RNA for ADP‐ribosyl cyclase in aldosterone‐producing adenomas

Yoko Ito, H. Mabuchi, Y. Takeda, 2005, Clinical endocrinology.

methods A novel method for measuring human hepatic lipase activity in postheparin plasma

H. Mabuchi, J. Kobayashi, Akihiro Inazu, 2007 .

The relationship between post-prandial plasma glucose and post-challenge plasma glucose in Japanese population.

M. Yamagishi, H. Mabuchi, H. Tanii, 2007, Diabetes research and clinical practice.

Molecular and functional characterization of familial chylomicronemia syndrome.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2017, Atherosclerosis.

Effect of common methylenetetrahydrofolate reductase gene mutation on coronary artery disease in familial hypercholesterolemia.

H. Mabuchi, A. Nohara, Akihiro Inazu, 2000, The American journal of cardiology.

Severely elevated serum triglycerides in a case of heterozygous familial hypercholesterolemia with the 317 cysteine to serine mutation in the LDL receptor gene.

H. Mabuchi, J. Kobayashi, 2005, European journal of internal medicine.

A 4-year trial of simvastatin in the treatment of patients with heterozygous familial hypercholesterolemia

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1996 .

A massive pulmonary hemorrhage resulting in cavitation occurring in a case of hemophilia A associated with diabetes mellitus.

H. Mabuchi, R. Takeda, 1974, Southern medical journal.

Effects of Hypertension and Type 2 Diabetes Mellitus on the Risk of Total Cardiovascular Events in Japanese Patients with Hypercholesterolemia: Implications from the Japan Lipid Intervention Trial (J-LIT)

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2007, Hypertension Research.

[Cholesteryl ester transfer protein (CETP) deficiency and increased HDL cholesterol levels (hyperalphalipoproteinemia)].

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1996, Rinsho byori. The Japanese journal of clinical pathology.

Cholesterol-years score is associated with development of senile degenerative aortic stenosis in heterozygous familial hypercholesterolemia.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2006, Journal of atherosclerosis and thrombosis.

Compound heterozygosity for mutations Asp611-->Tyr in KCNQ1 and Asp609-->Gly in KCNH2 associated with severe long QT syndrome.

K. Hayashi, H. Higashida, H. Mabuchi, 2005, Clinical science.

Cutoff point separating affected and unaffected familial hypercholesterolemic patients validated by LDL-receptor gene mutants.

H. Mabuchi, J. Kobayashi, M. Kawashiri, 2005, Journal of atherosclerosis and thrombosis.

Spontaneous development of left ventricular aneurysm in a patient with untreated cardiac sarcoidosis.

J. Taki, H. Mabuchi, T. Haraki, 2002, Circulation journal : official journal of the Japanese Circulation Society.

A missense mutation, A156T, in the alpha-galactosidase A gene causes typical Fabry disease.

I. Miyamori, H. Mabuchi, T. Konoshita, 2001, Clinical nephrology.

An LMNA variant is associated with dyslipidemia and insulin resistance in the Japanese.

H. Mabuchi, J. Koizumi, K. Yagi, 2002, Metabolism: clinical and experimental.

Common Mutation of 5, 10-Methylenetetrahydrofolate Reductase Accelerates Coronary Artery Disease in Familial Hypercholesterolemia

H. Mabuchi, A. Nohara, Akihiro Inazu, 2000 .

Asymptomatic versus Symptomatic Patients with Severe Aortic Stenosis

M. Toyofuku, M. Onoe, Y. Hiraoka, 2018, Scientific Reports.

Long-term probucol treatment results in regression of xanthomas, but in progression of coronary atherosclerosis in a heterozygous patient with familial hypercholesterolemia.

H. Mabuchi, J. Koizumi, K. Kajinami, 1996, Atherosclerosis.

Probucol aggravates long QT syndrome associated with a novel missense mutation M124T in the N-terminus of HERG.

K. Hayashi, H. Higashida, H. Mabuchi, 2004, Clinical science.

Therapeutic implications of cholesteryl ester transfer protein inhibitors in hyperlipidemia and low high-density lipoprotein-cholesterolemia.

H. Mabuchi, Akihiro Inazu, 2003, Current opinion in investigational drugs.

Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.

H. Mabuchi, Akihiro Inazu, J. Koizumi, 1994, The Journal of clinical investigation.

Difference between fasting and nonfasting triglyceridemia; the influence of waist circumference.

M. Yamagishi, K. Miura, H. Mabuchi, 2009, Journal of atherosclerosis and thrombosis.

The association of recurrence and bleeding events with mortality after venous thromboembolism: From the COMMAND VTE Registry.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2019, International journal of cardiology.

[Familial defective apolipoprotein B-100].

H. Mabuchi, A. Nohara, 1998, Ryoikibetsu shokogun shirizu.

A Rare Coincidence of Sitosterolemia and Familial Mediterranean Fever Identified by Whole Exome Sequencing.

K. Hayashi, M. Yamagishi, Y. Toyoshima, 2016, Journal of atherosclerosis and thrombosis.

Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2011, Atherosclerosis.

Septal wall thinning and systolic dysfunction in patients with hypertrophic cardiomyopathy caused by a cardiac troponin I gene mutation.

K. Hayashi, H. Mabuchi, M. Yamaguchi, 2002, American heart journal.

Characterization of a novel missense mutation E637K in the pore-S6 loop of HERG in a patient with long QT syndrome.

K. Hayashi, H. Higashida, H. Mabuchi, 2002, Cardiovascular research.

Clinical Features of Hypertrophic Cardiomyopathy Caused by a Novel Val85Leu Missense Mutation in the Cardiac Troponin T Gene(Cardiomyopathy, Clinical 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)

H. Mabuchi, M. Shimizu, H. Ino, 2005 .

Sex Differences in Clinical Outcomes After Percutaneous Coronary Intervention.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2022, Circulation journal : official journal of the Japanese Circulation Society.

Concomitant Mitral Regurgitation in Severe Aortic Stenosis　- A Report From the CURRENT AS Registry.

M. Toyofuku, C. Izumi, Takeshi Kimura, 2021, Circulation journal : official journal of the Japanese Circulation Society.

A novel method for determining functional LDL receptor activity in familial hypercholesterolemia: application of the CD3/CD28 assay in lymphocytes.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2009, Clinica chimica acta; international journal of clinical chemistry.

1,5-Benzoxathiepin derivatives. II. Synthesis and serotonin S2-receptor-blocking activity of aminoalkyl-substituted 3,4-dihydro-2H-1,5-benzoxathiepin-3-ols and related compounds.

H. Mabuchi, M. Hirata, Y. Kawamatsu, 1987, Chemical & pharmaceutical bulletin.

Studies on urinary and serum volatile substances.

H. Mabuchi, 1969, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Abstract 18143: Impact of FMO3 Gene Loss-of-Function Variants on Coronary Artery Disease in Japanese

M. Yamagishi, H. Mabuchi, A. Nohara, 2014 .

Sex Differences in Clinical Characteristics and Outcomes of Patients With Venous Thromboembolism　- From the COMMAND VTE Registry.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2019, Circulation journal : official journal of the Japanese Circulation Society.

Images in cardiovascular medicine. Adult patient with isolated noncompaction of ventricular myocardium.

H. Ikeda, H. Mabuchi, M. Shimizu, 2005, Circulation.

Risk evaluation of coronary heart disease and cerebrovascular disease by the Japan Atherosclerosis Society Guidelines 2002 using the cohort of the Holicos-PAT study.

M. Ohta, H. Mabuchi, J. Koizumi, 2005, Journal of atherosclerosis and thrombosis.

Association of angiopoietin-like protein3 (ANGPTL3) with HTGL and LPL activities in human plasma

Takeaki, H. Mabuchi, J. Kobayashi, 2010 .

Fatal hyperlipaemia in a case of metastatic breast cancer treated by tamoxifen

M. Noguchi, H. Mabuchi, A. Nonomura, 1987, The British journal of surgery.

Cholesteryl Ester Transfer Protein (CETP) Deficiency and CETP Inhibitors

H. Mabuchi, A. Nohara, Akihiro Inazu, 2014, Molecules and cells.

Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: implication from Japan Lipid Intervention Trial (J-LIT).

Y. Matsuzawa, K. Shimamoto, M. Matsuzaki, 2007, Atherosclerosis.

Telmisartan Treatment Decreases Visceral Fat Accumulation and Improves Serum Levels of Adiponectin and Vascular Inflammation Markers in Japanese Hypertensive Patients

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2007, Hypertension Research.